Transcept Pharmaceuticals Reports First Quarter 2011 Financial Results

Tuesday, May 17, 2011 General News
Email Print This Page Comment
Font : A-A+

Conference call scheduled for 4:30 PM Eastern time today

Transcept Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

March 31,

December 31,

2011

2010

Assets

(Unaudited)

Current assets:

Cash and cash equivalents

$        3,607

$ 13,720

Marketable securities

59,680

54,251

Other current assets

1,662

1,452

Total current assets

64,949

69,423

Property and equipment, net

511

614

Goodwill

2,962

2,962

Other assets

808

808

Total assets

$      69,230

$ 73,807

Liabilities and stockholders' equity

Current liabilities:

Deferred revenue, current portion

$        4,167

$   7,292

Other current liabilities

2,141

2,356

Total current liabilities

6,308

9,648

Other non-current liabilities

261

348

Total liabilities

6,569

9,996

Stockholders' equity:

Common stock and additional paid-in capital

160,797

160,023

Accumulated deficit

(98,153)

(96,214)

Accumulated other comprehensive income

17

2

Total stockholders' equity

62,661

63,811

Total liabilities and stockholders' equity

$      69,230

$ 73,807



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook